No drug-related safety signals identified by the independent Data and Safety Monitoring Board. BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious, inflammatory and degenerative diseases through a portfolio built around gelsolin technology, announced that it has expanded its clinical trial in severe COVID-19 to additional sites in Europe.
November 15, 2020
· 4 min read